Prelude Capital Management’s OptiNose OPTN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-24,000
| Closed | -$220K | – | 1258 |
|
|
2025
Q1 | $220K | Hold |
24,000
| – | – | 0.02% | 883 |
|
|
2024
Q4 | $160K | Hold |
24,000
| – | – | 0.01% | 1037 |
|
|
2024
Q3 | $241K | Hold |
24,000
| – | – | 0.01% | 976 |
|
|
2024
Q2 | $374K | Hold |
24,000
| – | – | 0.03% | 683 |
|
|
2024
Q1 | $526K | Buy |
24,000
+6,000
| +33% | +$133K | 0.03% | 617 |
|
|
2023
Q4 | $348K | Buy |
18,000
+6,000
| +50% | +$110K | 0.02% | 678 |
|
|
2023
Q3 | $221K | Buy |
12,000
+2,000
| +20% | +$36K | 0.01% | 843 |
|
|
2023
Q2 | $185K | Sell |
10,000
-463
| -4% | -$11K | 0.01% | 856 |
|
|
2023
Q1 | $303K | Buy |
10,463
+586
| +6% | +$15.6K | 0.02% | 637 |
|
|
2022
Q4 | $274K | Buy |
9,877
+10
| +0.1% | +$380 | 0.01% | 825 |
|
|
2022
Q3 | $542K | Sell |
9,867
-133
| -1% | -$7.3K | 0.02% | 624 |
|
|
2022
Q2 | $549K | Buy |
10,000
+1,667
| +20% | +$61.3K | 0.02% | 771 |
|
|
2022
Q1 | $309K | Buy |
8,333
+3,533
| +74% | +$126K | 0.01% | 1064 |
|
|
2021
Q4 | $117K | Hold |
4,800
| – | – | ﹤0.01% | 1686 |
|
|
2021
Q3 | $216K | Buy |
4,800
+2,400
| +100% | +$101K | 0.01% | 1317 |
|
|
2021
Q2 | $112K | Buy |
2,400
+800
| +50% | +$40.9K | ﹤0.01% | 1451 |
|
|
2021
Q1 | $89K | Buy |
+1,600
| New | +$97.3K | ﹤0.01% | 1443 |
|
|
2020
Q1 | – | Sell |
-20
| Closed | -$3K | – | 1869 |
|
|
2019
Q4 | $3K | Buy |
+20
| New | +$2.59K | ﹤0.01% | 1815 |
|
|
2018
Q3 | – | Sell |
-11,382
| Closed | -$4.78M | – | 1963 |
|
|
2018
Q2 | $4.78M | Sell |
11,382
-569
| -5% | -$192K | 0.3% | 53 |
|
|
2018
Q1 | $3.59M | Buy |
11,951
+1,459
| +14% | +$404K | 0.26% | 59 |
|
|
2017
Q4 | $2.98M | Buy |
+10,492
| New | +$2.95M | 0.24% | 80 |
|
Prelude Capital Management's OPTN Position: Q2 2025 in Review
Prelude Capital Management sold out of OptiNose (OPTN) in Q2 2025, closing a stake of 24,000 shares — an estimated $220K sold.
Prelude Capital Management first reported a position in OPTN in Q4 2017 and held it in 21 quarters. The position peaked at $4.78M in Q2 2018. 0 funds tracked by Wall St. Rank hold OPTN as of Q2 2025.
- Prelude Capital Management reported no remaining OptiNose position as of Q2 2025 after selling out during the quarter.
- Prelude Capital Management sold 24,000 OptiNose shares in Q2 2025, an estimated $220K.
- Prelude Capital Management first reported a position in OptiNose in Q4 2017 and held it in 21 quarters.
- Prelude Capital Management's OptiNose position peaked at $4.78M in Q2 2018.
- 0 funds tracked by Wall St. Rank held OptiNose as of Q2 2025.
Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.